Chemotherapy and quality of life among patients with multiple myeloma: a 3-year prospective study
Aim. Little is known about change in quality of life among multiple myeloma survivors. We examined quality of life to assess demographic, psychosocial, and clinical risk factors for poor outcomes depending on appearance of cardiovascular events among long-term survivors of multiple myeloma. Metho...
Saved in:
| Main Author: | B. B. Samura |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaporizhzhia State Medical and Pharmaceutical University
2016-08-01
|
| Series: | Zaporožskij Medicinskij Žurnal |
| Subjects: | |
| Online Access: | http://zmj.zsmu.edu.ua/article/view/79763/77607 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
QUALITY OF PATIENT’S LIFE AFTER MULTIPLE MYELOMAREGRESSION
by: Yu. M. Kolesnik, et al.
Published: (2014-12-01) -
Circulating VE-catherin and prognosis of cardiovascular events in remission of multiple myeloma
by: B. B. Samura
Published: (2016-06-01) -
Value of P-selectin in the prognosis of cardiovascular events in patients with multiple myeloma
by: M. O. Panasenko, et al.
Published: (2022-08-01) -
Circulating sST2 and prognosis of cardiovascular events in remission of multiple myeloma
by: M. O. Panasenko, et al.
Published: (2022-10-01) -
Prognostic value of P-selectin and sST2 in patients with multiple myeloma
by: M. O. Panasenko, et al.
Published: (2022-11-01)